Articles On Global Health (ASX:GLH)

The Dimerix Ltd (ASX: DXB) share price is rising today after the biopharmaceutical company announced its involvement in a trial on COVID-19 therapies. Dimerix will be involved in the trial, named CLARITY 2.0, which has received approval fr...

Summary Amid growing adoption of digital platforms, Global Health registered a robust half-year performance. Total customer revenue for the period was up by 20% on PCP. The MasterCare platform for community health care providers exper...

Summary Global Health Ltd (ASX:GLH) said Lifecard Patient Portal is seeing high demand as health delivery organisations have embraced digital engagement with patients. Lifecard Patient Portal assists consumers and doctors in managing d...

The Global Health Limited (ASX: GLH) share price is lifting higher today after the company announced it was experiencing strong demand for its Lifecard Patient Portal. At the time of writing, the Global Health share price is up 1.12% at 45...

The Dimerix Ltd (ASX: DXB) share price lifted higher today after the company announced the start of its second clinical study on lead drug candidate, DMX-200. At the time of writing, the Dimerix share price is up 6.1% at 26 cents. What’s d...

Summary eSense is working towards developing a superior organic sanitiser providing extra protection against bacteria and viruses. The Company tested two proprietary terpenes profiles, TRP-ENV and TRP-COV, to ascertain their anti-viral...

Summary As of 18 November 2020, Asia has 9.8 million ‘reported’ cases and 161,000 deaths. Countries are now trying their best to control the spread of the virus and heal those that are already infected. Restricted or complete lockdown...

Global Health Limited (ASX: GLH) shares rocketed up in early trade today after the announcement of a major contract win with the Western Australian Government. Before the market halt this morning, the Global Health share price was trading...

The Global Health Limited (ASX: GLH) share price is on the rise today after the company released a positive announcement regarding a significant contract win. In early morning trade, shares in the digital health company were down 6.5% to 3...

The 11 startups the UNSW Founders invested in as part of its 2020 10x accelerator program make their public debut over the coming week as part of two Demo Nights. The first, the 10x Demo Night, is this afternoon, October 28. The 2020 cohort...

The Global Health Limited (ASX: GLH) share price has rocketed higher following the release of a trading update for FY21. On the opening bell, shares in the med tech company lifted 38% to 47 cents from the news. However, its shares have sli...

Global Health Limited (ASX: GLH) has been developing software for the healthcare industry for more than 30 years. Today it announced a new partnership between the company’s Lifecard consumer health platform with Asthma Australia. The news...

The share price of Australian healthcare software provider Global Health Ltd [ASX:GLH] has rocketed up today after partnering with Asthma Australia. At the time of writing, the GLH share price are up ~70%, or 16 cents, to trade at 39 cents...

Health software stock Global Health (ASX:GLH) has joined the club of ASX asthma stocks. ... Read More The post ASX asthma stocks: Global Health becomes the latest contender appeared first on Stockhead.

As the COVID-19 pandemic continues, whether the economy will ever be the same again remains is still a significant unknown. The literal shutting down of much of the economy has resulted in higher unemployment, plunging GDP and dented consum...

The Victorian government today announced the eagerly anticipated roadmap out of COVID-19 lockdown. It features several steps that reflect a much slower relaxing of restrictions than last time around. While the government has provided a prov...

A quick wrap of the ASX’s key winners and losers on Wednesday, July 29. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 529 stocks rose, 801 declined and...

A quick wrap of the ASX’s key winners and losers on Tuesday, July 28. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 601 stocks rose, 779 declined and 72...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

A quick wrap of the ASX’s key winners and losers on Friday, July 17. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 712 stocks rose, 606 declined and 789...

Summary While the benchmark index ended almost flat, two healthcare small cap stocks ended substantially higher. Australian healthcare software provider Global Health Limited signed a 3-year contract with Peninsula Health. Post the anno...

A quick wrap of the ASX’s key winners and losers on Tuesday, July 7. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 571 stocks rose, 750 declined and 786...

Summary While the benchmark index ended almost flat, two healthcare small cap stocks ended substantially higher. Australian healthcare software provider Global Health Limited signed a 3-year contract with Peninsula Health. Post the anno...

Global Health (ASX:GLH) continues to win new business in Victoria, with the state again re-entering lockdown proving a catalyst for the healthcare software provider. The company revealed today it had signed Peninsula Health as a provider fo...

Fresh off its first sale in the US and positive results from a John Hopkins School of Medicine study, LBT Innovations (ASX:LBT) shares are set to rise again following a European marketing deal. The Adelaide company makes automated microbiol...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

A quick wrap of the key winners and losers on Friday, June 26. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 907 stocks rose, 484 declined and 722 were...

Last week in our discussion with Bourse Communication founder and Managing Director Rod North, we examined how COVID-19 compared to other great market impacting events such as the 1987 crash the recession we had to have. This week, we look...

In our latest Finfeed podcast, Mathew Cherian, CEO at Global Health Limited (ASX: GLH) speaks with us about the digitisation of the healthcare industry and what the future of healthcare looks like. Global Health is an ASX listed leading pro...

Almost all of the ASX’s health small caps have visions as ambitious as the Australian and state governments’ broader health objectives for society as a whole. The combined market caps of all ASX health companies under $500m is approximately...

A visit to a new GP always involves a form on a clipboard. You fill in, with a varying degree of honesty, how much you drink, your family’s medical history, whether you smoke or take illicit drugs, and hand it over to the receptionist. At n...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Luck’s a fortune, eh? Atomo Diagnostics’ (ASX:AT1) ASX listing had been in the offing for months, based on its rapid blood-based diagnostic device for HIV that’s the only self-administered HIV assay approved by the local Therapeutic Goods A...

  Medtech Atomo Diagnostics had an unusual start to life as a listed company today, holding a virtual bell-ringing as it became the first company to list on the ASX since January. But coronavirus concerns proved to be boon for the rapid blo...

Rapid blood test startup Atomo Diagnostics is playing its part in the fight against coronavirus, signing a deal with French diagnostics company, NG Biotech, to supply up 2.465 million of its rapid, blood-based COVID-19 tests in 2020. The s...

Melbourne-based Global Health (ASX: GLH) was already on a roll with strong revenue growth before the coronavirus outbreak, but now its software and videoconferencing platform for doctors is more relevant than ever. The company's practice...

The George Institute for Global Health has announced three Australian investors have committed $53 million to support the commercialisation of its research.

Ramifications from the spread of the coronavirus continue to cut deep. The World Health Organization (WHO) reports the total cases to number more than 60,000 worldwide, following the more than 13,332 extra cases Chinese authorities reported...

With triple the number of sepsis cases in Australia, small cap biotech company Cynata Therapeutics (ASX:CYP) hopes to wage a new war on blood infections. Last Friday the world learned blood infections were on the rise, with researchers show...

Asia is rising as a healthcare spender, matching incomes and the long-feared elderly population boom. The region is a major part of a surge in health spending that is expected over the next few years, as rising lifestyle illnesses and ages...

Health care is a huge part of the global economy and accounts for one of the fastest growing sectors. Traditionally, stocks under this sector fall under the defensive category. Health care sector includes various businesses, which broadly f...

In Australia, there are plenty of high-quality health care companies, most of which have delivered excellent returns. Investment in health care stocks is high yielding; however, it does include risks. If undergoing clinical studies fail to...

Introduction S&P/ASX 200 Index recently made its 52-week high level of $6875.50 on July 30, 2019. At the time of writing, the index was trading at $6653 (13:56 (UTC+11)), which is a ~3.2% decline from the 52-week high level. In between...

Australian Health Care is a dynamic sector with a potential to generate significant profits in the least amount of time, something, what investors eye for, while pouring cash in Stocks. In this article we will be digging into four Health Ca...

The Spark Festival, Australia’s largest event for startups, innovators and entrepreneurs, kicks off next week with more than 130 events, many of them free, happening over 17 days. Spark Festival 2019 runs October 10 – 27 and with so much...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

On 1 October 2005, I was only 20 metres away from a large bomb that went off in the heart of Kuta. The 2005 Bali bombings were a series of terrorist attacks across two sites in Jimbaran Bay and in Kuta - 30km away from each other, both in s...

Digital healthcare service has evolved as one of the fastest-growing industries in the modern era. Introduction of technology in medical science has emerged as one of the biggest blessings for human. Digitally connected network systems have...